A High‑Stakes Acquisition
The Los Angeles Dodgers made a splash in the trade market by securing Tarik Skubal, a two‑time American League Cy Young Award winner, as a centerpiece for their starting rotation. The move comes at a time when the club is grappling with a slew of injuries among its veteran arms, and Skubal’s pedigree was seen as a potential remedy.
Skubal joins a rotation that already includes veteran left‑hander Blake Snell and power right‑hander Tyler Glasnow, both of whom have endured multiple trips to the injured list. Adding to the mix, Shohei Ohtani, who is being carefully managed after a historic two‑way season, will see limited innings, leaving the bulk of the workload to a staff that has already been stretched thin.
Rotation Realities
The 27‑year‑old right‑hander’s journey includes a Tommy John surgery during his college years, yet since his return he has posted a track record of durability that outpaces many of his peers in the Dodgers’ bullpen. His recent performances have been marked by high strikeout rates and the ability to eat innings, traits that the front office hopes will translate into postseason stability.
A Question of Care
Dr. Neil ElAttrache, the Dodgers’ chief orthopedic surgeon, performed the initial elbow operation on Skubal and has since been vocal about the need to balance performance with health. Manager Dave Roberts, meanwhile, has repeatedly described Skubal as the “guy they needed,” but his comments have leaned toward exploiting the pitcher’s upside rather than instituting protective limits.
In practice, Skubal has been asked to throw deep into games, often surpassing 100 pitches with only a day or two of rest before the next start. A late‑August outing against the Pirates, which followed a dominant seven‑inning stretch, exemplifies the aggressive usage pattern that has alarmed some observers.
Strategic Calculations
The front office appears to view Skubal as a short‑term rental, a tactical acquisition aimed at immediate contention rather than a long‑term investment. This stance is underscored by the team’s reluctance to lock the pitcher into a multi‑year contract, despite earlier expectations of a permanent deal.
With the NL West already decided, the Dodgers’ focus shifts to playoff readiness, and Skubal’s presence could tip the scales against rivals such as the Brewers and Braves. Yet the very same aggressive deployment that promises short‑term gains may also jeopardize the pitcher’s arm, raising a critical question about the balance between ambition and stewardship.